In an Astonishing Feat, a New Drug Reversed Paralysis in Mice With Spinal Cord Injury – ScienceAlert

US scientists have developed a new form of drug that promotes the regeneration of cells and reversed paralysis in mice with spinal injuries, allowing them to walk again within four weeks of treatment. The research was published in the journal Science on Thursday, and the team of Northwestern University scientists behind it hope to approach the Food and Drug Administration (FDA) as early as next year to propose human trials

Read more
CELULARITY INC Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) – marketscreener.com

The following discussion and analysis should be read in conjunction with ourfinancial statements and accompanying notes included herein and the financialstatements and accompanying notes thereto for the fiscal year ended December 31,2020 and the related Management's Discussion and Analysis of Financial Conditionand Results of Operations, which are contained in the prospectus, dated August12, 2021 (the "Prospectus") filed by Celularity Inc.

Read more
PRESS RELEASE : Vita 34 again increases sales and margins in the third quarter – marketscreener.com

DGAP-News: Vita 34 AG / Key word(s): Quarter Results Vita 34 again increases sales and margins in the third quarter 2021-11-11 / 07:30 The issuer is solely responsible for the content of this announcement. ----------------------------------------------------------------------------------------------------------------------- Vita 34 again increases sales and margins in the third quarter

Read more
Cord blood cell transplantation and curcumin administration tested as therapy of Tay-Sachs disease – EurekAlert

image:(a) Dynamic changes in the HexA activity in the TSD patients plasma after UCBCT and curcumin administration; normal level of HexA activity observed in healthy donors is 24148 nmol/mL/h; (b) Dynamic changes in the HexA concentration in the TSD patients serum after UCBCT and curcumin administration. The HexA concentration range measured in a cohort of healthy donors (n = 10) is shown in gray; (c) Dynamic changes in the GM2 level in the TSD patients plasma after UCBCT and curcumin administration.

Read more